FisclearFisclear

Financial Comparison

Apollo Hospitals Enterprise Limited vs Cipla Limited

Click a ticker to view the full analysis.

APOLLOHOSP.NS vs

In short

Cipla Limited is the more profitable of the two, keeping 14.0% of revenue as net profit against 7.8% for Apollo Hospitals Enterprise Limited. Apollo Hospitals Enterprise Limited trades at the higher trailing P/E (56.2× vs 31.9× for Cipla Limited), so investors pay more for each dollar of its earnings. Fisclear flags 1 medium- or high-severity risk for Apollo Hospitals Enterprise Limited and 0 for Cipla Limited.

Based on filings for periods ending 31 Mar 2026 (APOLLOHOSP.NS) and 31 Mar 2026 (CIPLA.NS) · Updated

FisclearScore Comparison

APOLLOHOSP.NS68Strong
CIPLA.NS51Fair
Quality+6
95
89
Efficiency+25
72
47
Value+36
62
26
Cashflow+30
55
25
Regime
55
55
Peers+1
59
58

FisclearScore is a quantitative model. APOLLOHOSP.NS shown solid · CIPLA.NS shown dashed. Not financial advice.

MetricAPOLLOHOSP.NSCIPLA.NS
Price₹7,908.00₹1,310.50
Market Cap₹1.14T₹1.06T
P/E (TTM)56.2x31.9x
P/B12.0x3.1x
Beta0.170.09
Div Yield0.26%0.99%
Revenue (TTM)₹249.1B₹277.1B
Net Income₹19.4B₹38.8B
Gross Margin47.5%62.3%
Risk Flags1 flag—
Full APOLLOHOSP.NS Report →Full CIPLA.NS Report →

Related comparisons

CIPLA.NS vs Sun PharmaceuticalAPOLLOHOSP.NS vs Sun PharmaceuticalCIPLA.NS vs Dr. Reddy's LaboratoriesAPOLLOHOSP.NS vs Dr. Reddy's LaboratoriesCIPLA.NS vs DIVISLAB.NSCIPLA.NS vs TORNTPHARM.NS

Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.